Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Revolve Stock Is Strong Due to the Company’s Deft Response to Covid-19

By Tom Kerr, InvestorPlace Contributor
RVLV stock was recently at an all-time high after a year of successfully adapting to the changes the pandemic brought to clothing sales.

Why Tilray Might Be Looking Forward to the New Normal

By Josh Enomoto, InvestorPlace Contributor
TLRY stock may be trading in one of the most saturated and competitive markets, but the new normal could be a benefactor.

Why Wall Street Is Giving Up on GameStop

By Wayne Duggan, InvestorPlace Contributor
Analysts are flat out dropping coverage of GME stock completely. Wall Street is starting to simply ignore meme stocks, and you should too.

Hot Stock or Hot Air: Analyzing the Virgin Galactic Battle

By Ian Bezek, InvestorPlace Contributor
SPCE stock is bitterly controversial right now. Here are four key bull and bear talking points, and how investors should view the argument.

The Polkadot Tech Is Impressive But That’s Not the Only Story

By Josh Enomoto, InvestorPlace Contributor
Underlining the Polkadot platform is an incredible blockchain technology but that alone won’t bolster its economic proposition.

Buy Nvidia Stock For Long-Term Growth, Not Quick Profits

By Louis Navellier and the InvestorPlace Research Staff
NVDA stock's price has gained over 500% since 2019, and NVIDIA can continue its growth story with tech for gaming, crypto and AI.

Amazon Is the Best of the Best, But Approach With Caution

By Nicolas Chahine, InvestorPlace Contributor
AMZN stock chart is showing extreme breakout conditions for traders to chase with fast hands, but for investors, patience is a saner course of action.

The Real Value of Novavax Lies in Its Pipeline, Not the Pandemic

By Chris Markoch, InvestorPlace Contributor
NVAX stock is beginning to look like all the good news is priced in. However, a successful Covid-19 vaccine may be a catalyst for other vaccines.

Virgin Galactic Struggles to Stay in Orbit Above $50

By Will Ashworth, InvestorPlace Contributor
Virgin Galactic announced June 25 that FAA was good with full commercial launch. SPCE stock blasted off and fell back to earth. Where to next?

Orphazyme A/S May Look Like a Long Shot, but Things Aren’t That Dire

By Thomas Niel, InvestorPlace Contributor
How far could ORPH stock climb if it gets squeezed? Maybe not back above $77 per share. But, a move back to $15-$20 per share could be attainable. For investors with a healthy risk appetite, and a stomach for volatility, consider it a buy at today's prices (around $7.25 per share).

The Outlook for Ocugen Stock Has Deteriorated Further

By Larry Ramer, InvestorPlace Contributor
Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.

Workhorse Stock Did Great in June, But It’s a Risky Buy

By Will Ashworth, InvestorPlace Contributor
It might be tempting to look at the recent hype for WKHS stock and jump on board, but the company's future is unsure for now.

Near-Doubled Revenues Show High Tide Is a Canna-Biz Contender

By Louis Navellier and the InvestorPlace Research Staff
You might find a hidden gem in the retail marijuana niche with HITI stock, as it should move higher due to a value-added acquisition.

Consider AST SpaceMobile Stock a Worthwhile Moonshot

By Thomas Niel, InvestorPlace Contributor
Risk remains high, as its technology could fail to deliver, sending shares cratering towards zero. There may only be a moderate chance of hitting its long-term projections. Even so, hopping into ASTS stock now, after its pop, but while it's still on the launching pad, may be a high risk worth taking.

Long-Term Investors Should Buy Nvidia Stock on Weakness

By Chris Markoch, InvestorPlace Contributor
Traders may not like NVDA stock, but it still looks like a sound long-term investment. Nvidia's outlook depends on one's objective.

3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory

By Alex Sirois, InvestorPlace Contributor
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.

Investors Need to Give Stem Stock Time to Ripen

By Ian Bezek, InvestorPlace Contributor
Stem is a compelling play on the green energy revolution. Just don't count on STEM stock for short-term gains.

Are Chamath Palihapitiya’s 4 New Biotech SPACs Worth a Look?

By Faizan Farooque, InvestorPlace Contributor
In Chamath Palihapitiya's latest SPAC empire-building move, his four new new biotech SPACs in the genomics and biotech space are making waves.

No Matter How ‘Techy’ Tractor Maker Deere Might Seem, It’s No Tech Stock

By Dana Blankenhorn, InvestorPlace Contributor
DE stock rolled over after the equipment maker recorded a strong April quarter and hiked its dividend. But there’s a limited opportunity for Deere & Company's fancy tractors and combines.
Load More Articles